Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Kent Leslie

Vice President
Life Science
Amylyx Pharmaceuticals Inc
United States of America


Kent Leslie joined Amylyx Pharmaceuticals in 2015 and serves as Vice President of Research. Kent received his M.Sc in Biotechnology from Brown University while completing research in the lab of Dr. Richard Bennett. Prior to receiving his Master’s degree, Kent received Bachelor’s degrees in Biology and Economics from Brown University. 

Research Interest

mylyx is developing a proprietary therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases that targets the neuroinflammation and nerve cell death that characterize these disorders. The company’s therapeutic, AMX0035, is a proprietary combination of existing compounds that Amylyx has demonstrated have synergistic effects in preventing nerve cell death and neurotoxic inflammation in multiple preclinical models. 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences